VERTEX PHARMACEUTICALS INC / MA (VRTX) Stock buybacks 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$2.0BFY2025 · since FY2016: $0 → $2.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.0B | +71.4% |
| FY2024 | $1.2B | +175.3% |
| FY2023 | $427.6M | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $1.4B | +164.4% |
| FY2020 | $539.1M | +189.8% |
| FY2019 | $186.0M | -46.9% |
| FY2018 | $350.0M | — |
| FY2017 | $0 | — |
| FY2016 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRTX financial trends
VRTX RevenueVRTX Net incomeVRTX Net marginVRTX Gross profitVRTX Gross marginVRTX Operating incomeVRTX Operating marginVRTX Operating cash flowVRTX Free cash flowVRTX Capital expendituresVRTX Return on equityVRTX Dividends paidVRTX Total assetsVRTX Total liabilitiesVRTX Shareholders’ equityVRTX overview →